CRC
GTHX

Curi RMB Capital’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Curi RMB Capital’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-70,795
Closed -$306K – 574
2024
Q1 		$306K Buy
+70,795
New +$247K 0.01% 497

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Curi RMB Capital's GTHX Position: Q2 2024 in Review

Curi RMB Capital sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2024, closing a stake of 70,795 shares — an estimated $306K sold.

Curi RMB Capital first reported a position in GTHX in Q1 2024 and held it in 1 quarter. The position peaked at $306K in Q1 2024. 88 funds tracked by Wall St. Rank hold GTHX as of Q2 2024.

  • Curi RMB Capital reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Curi RMB Capital sold 70,795 G1 Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $306K.
  • Curi RMB Capital first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Curi RMB Capital's G1 Therapeutics, Inc. Common Stock position peaked at $306K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Curi RMB Capital's 13F filing for Q2 2024, filed 13 Aug 2024.